tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 137 are a HOLD (43.77%), 158 are a BUY (50.48%), 18 are a SELL (5.75%).
Analyst David Risinger, currently employed at LEERINK, carries an average stock price target met ratio of 70.98% that have a potential upside of 32.96% achieved within 311 days. Previously, David Risinger worked at BAML, MORGAN STANLEY.
David Risinger’s has documented 592 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 25-Jun-2026.
Analyst best performing recommendations are on TECX (TECTONIC THERAPEUTIC).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 7/31/2020. The price target of $70 was fulfilled within 5 days with a profit of $8.81 (14.4%) receiving and performance score of 28.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2020
$273
$19.65 (7.76%)
$262
16 days ago
(23-Jun-2026)
14/16 (87.5%)
$38.24 (16.29%)
409
Buy Since 12-Sep-2025
$298
$44.65 (17.62%)
$298
16 days ago
(23-Jun-2026)
2/7 (28.57%)
$63.24 (26.94%)
35
Buy Since 23-Jan-2023
$235
$-18.35 (-7.24%)
$236
1 months 24 days ago
(15-May-2026)
8/8 (100%)
$24.61 (11.70%)
142
Buy Since 06-Feb-2020
$249
$-4.35 (-1.72%)
$249
2 months 8 days ago
(01-May-2026)
35/35 (100%)
$42.4 (20.52%)
446
Buy Since 24-Jan-2022
$278
$24.65 (9.73%)
$270
2 months 9 days ago
(30-Apr-2026)
21/24 (87.5%)
$66.68 (31.55%)
515
Which stock is David Risinger is most bullish on?
Which stock is David Risinger is most reserved on?
What Year was the first public recommendation made by David Risinger?
